Face-to-face 3-year comparative effectiveness and safety of dabigatran and rivaroxaban, standard and reduced doses, for nonvalvular atrial fibrillation: A cohort study in the french nationwide claims database

Affiliation auteurs!!!! Error affiliation !!!!
TitreFace-to-face 3-year comparative effectiveness and safety of dabigatran and rivaroxaban, standard and reduced doses, for nonvalvular atrial fibrillation: A cohort study in the french nationwide claims database
Type de publicationJournal Article
Year of Publication2020
AuteursBlin P, Cottin Y, Dureau-Pournin C, Abouelfath A, Lassalle R, Guiard E, Balestra A, Mismetti P, De Pouvourville G, Droz-Perroteau C, Benichou J, Moore N
JournalPHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume29
Pagination587-588
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1053-8569